Financial
CVC
UNITED KINGDOM WEBSITE : CVC.COM
CVC has established itself, over four decades, as one of the leading private equity investors. The platform has developed an integrated model structured around seven complementary strategies: Europe / Americas, Asia, Strategic Opportunities, Catalyst, Secondaries, Credit and Infrastructure, deployed within a single organisation mobilising more than 1,600 employees across 30 offices on six continents. The firm manages €212 billion in assets under management and backs more than 150 companies. At the heart of the buyout engine sits the Europe/Americas strategy, which captures the bulk of the capital with €84 billion in AUM and 91 active investments run by a team of 189 professionals; it favours control or co-control stakes in market-leading, cash-generating companies firmly anchored in defensible positions. CVC directs its investments primarily across the following sectors: food processing, life sciences, software, industrial services, industrial equipment and concentrates primarily on: United states, United kingdom and Italy, where its longstanding presence (21 offices across EMEA and the Americas) gives it proprietary sourcing. Recent transactions by the fund notably include Corbion, Cernaval and Fibrotex. The firm also highlights specific asset characteristics that underpin its investment thesis: predictable cash flows, diversified customer bases and defensible leadership positions, keeping market risk as a minimal component of each thesis. The average EBITDA multiple paid by CVC over the past 10 years stands at 13.5x.
CVC has established itself, over four decades, as one of the leading private equity investors. The platform has developed an integrated model structured around seven complementary strategies: Europe / Americas, Asia, Strategic Opportunities, Catalyst, Secondaries, Credit and Infrastructure, deployed within a single organisation mobilising more than 1,600 employees across 30 offices on six continents. The firm manages €212 billion in assets under management and backs more than 150 companies. At the heart of the buyout engine sits the Europe/Americas strategy, which captures the bulk of the capital with €84 billion in AUM and 91 active investments run by a team of 189 professionals; it favours control or co-control stakes in market-leading, cash-generating companies firmly anchored in defensible positions. CVC directs its investments primarily across the following sectors: food processing, life sciences, software, industrial services, industrial equipment and concentrates primarily on: United states, United kingdom and Italy, where its longstanding presence (21 offices across EMEA and the Americas) gives it proprietary sourcing. Recent transactions by the fund notably include Corbion, Cernaval and Fibrotex. The firm also highlights specific asset characteristics that underpin its investment thesis: predictable cash flows, diversified customer bases and defensible leadership positions, keeping market risk as a minimal component of each thesis. The average EBITDA multiple paid by CVC over the past 10 years stands at 13.5x.
48 Deals with CVC
| Date | Type | Target | Acquirer | Sector | Rev | EBITDA | EV | xRev | xEBITDA |
|---|---|---|---|---|---|---|---|---|---|
| 07/2022 | 100% | TMF Group NETHERLANDS | CVC / Adia | Consulting & Audit | |||||
| 03/2022 | Majority | Rgi Group ITALY | CVC | Industry-Specific Software | |||||
| 12/2021 | Majority | Authentic Brands Group UNITED STATES | CVC / HPS Investment Partners | Fashion & Apparel | |||||
| 11/2021 | 100% | Lipton Teas and Infusions NETHERLANDS | CVC | Beverages | |||||
| 07/2021 | 100% | Panzani FRANCE | CVC | Food Products | |||||
| 03/2021 | Minority | Cooper-Vemedia FRANCE | CVC | Pharma & Biotech | |||||
| 01/2020 | 100% | D-Marin GREECE | CVC | Infrastructure & Ground Services | |||||
| 01/2020 | Minority | Ecovadis FRANCE | CVC | Industry-Specific Software | |||||
| 01/2019 | Majority | April FRANCE | CVC | Brokerage | |||||
| 07/2018 | Majority | Linde Gases UNITED STATES | Messer Group / CVC | Specialty Chemicals | |||||
| Average (10 yrs) | 2.8x | 13.5x | |||||||
| Median (10 yrs) | 2.5x | 12.3x | |||||||
